M.F. Dumon
Impact in
- Virology top 5%
- HIV Research and Treatment
- Emergency Medicine top 5%
- HIV-related health complications and treatments
Papers in
- Virology 2
- HIV Research and Treatment 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Co-authors
- Michel ClercE. PeuchantNicolas DuvergerM. C. ReceveurMichel Le BrasMarie‐Christine Delmas‐BeauvieuxC. ConriClaire Sergeant
- Journals
- Clinical Chemistry (2 papers)Journal of Clinical Investigation (2 papers)European Journal of Clinical Investigation (2 papers)Cornea (1 paper)Chemistry and Physics of Lipids (1 paper)
- Partner nations
- FranceUnited StatesJapan
In The Last Decade
M.F. Dumon
15 papers receiving 450 citations
Peers
Comparison fields: 5 of 67
- Virology 83
- Emergency Medicine 128
- Endocrinology, Diabetes and Metabolism 133
- Behavioral Neuroscience 24
- Infectious Diseases 94
Countries citing papers authored by M.F. Dumon
This map shows the geographic impact of M.F. Dumon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Dumon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Dumon more than expected).
Fields of papers citing papers by M.F. Dumon
This network shows the impact of papers produced by M.F. Dumon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Dumon. The network helps show where M.F. Dumon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.F. Dumon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 89 | |
| 2 | 1994 | 143 | |
| 3 | 1994 | 98 | |
| 4 | [Demonstration of the anti-lipid peroxidation effect of 3',5,7-trihydroxy-4'-methoxy flavone rutinoside: in vitro study]. | 1994 | 9 |
| 5 | 1993 | 54 | |
| 6 | 1993 | 7 | |
| 7 | 1992 | 8 | |
| 8 | [First observations on the main plasma parameters of oxidative stress in homozygous sickle cell disease]. | 1992 | 7 |
| 9 | 1991 | 9 | |
| 10 | 1988 | 3 | |
| 11 | 1987 | 8 | |
| 12 | 1987 | 10 | |
| 13 | 1986 | 6 | |
| 14 | 1986 | 13 | |
| 15 | 1984 | 3 |
About M.F. Dumon
M.F. Dumon is a scholar working on Virology, Endocrinology, Diabetes and Metabolism, Biochemistry, Emergency Medicine and Hematology, having authored 15 papers that have together received 467 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Nuclear Structure and Function (4 papers), Machine Learning in Bioinformatics (2 papers), HIV Research and Treatment (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Cholesterol and Lipid Metabolism (2 papers), HIV-related health complications and treatments (2 papers) and Antioxidant Activity and Oxidative Stress (2 papers). The work is most often cited by research in Virology (83 citations), Emergency Medicine (128 citations), Endocrinology, Diabetes and Metabolism (133 citations), Behavioral Neuroscience (24 citations) and Infectious Diseases (94 citations). M.F. Dumon has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Michel Clerc, E. Peuchant, Nicolas Duverger, M. C. Receveur, Michel Le Bras, Marie‐Christine Delmas‐Beauvieux, C. Conri, Claire Sergeant, Isabelle Pellegrin and Hervé Fleury. Their work appears in journals such as Clinical Chemistry, Journal of Clinical Investigation, European Journal of Clinical Investigation, Cornea and Chemistry and Physics of Lipids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.